Jan Dutz

9.1k total citations · 1 hit paper
160 papers, 6.1k citations indexed

About

Jan Dutz is a scholar working on Immunology, Rheumatology and Dermatology. According to data from OpenAlex, Jan Dutz has authored 160 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Immunology, 52 papers in Rheumatology and 34 papers in Dermatology. Recurrent topics in Jan Dutz's work include Psoriasis: Treatment and Pathogenesis (34 papers), T-cell and B-cell Immunology (30 papers) and Immune Cell Function and Interaction (25 papers). Jan Dutz is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (34 papers), T-cell and B-cell Immunology (30 papers) and Immune Cell Function and Interaction (25 papers). Jan Dutz collaborates with scholars based in Canada, United States and United Kingdom. Jan Dutz's co-authors include Rusung Tan, Mehran Ghoreishi, Diane T. Finegood, Jacqueline D. Trudeau, Sunil Kalia, Mark G. Kirchhof, Janet Pope, Wayne Gulliver, Charles Lynde and Robert Bissonnette and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Jan Dutz

154 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis

2015 660 citations Charles Lynde, Jan Dutz et al. profile →

Peers

Countries citing papers authored by Jan Dutz

Since Specialization

Citations

This map shows the geographic impact of Jan Dutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Dutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Dutz more than expected).

Fields of papers citing papers by Jan Dutz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Dutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Dutz. The network helps show where Jan Dutz may publish in the future.

Co-authorship network of co-authors of Jan Dutz

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Dutz. A scholar is included among the top collaborators of Jan Dutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Dutz. Jan Dutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Just the facts: diagnosis and management of Stevens–Johnson syndrome/toxic epidermal necrolysis 2026 ·Canadian Journal of Emergency Medicine ·(unknown), Marlene Dytoc, (unknown), Jan Dutz	0
2	Clinical Characteristics and Evolution of Interstitial Lung Disease in Subtypes of Idiopathic Inflammatory Myositis With Prevalent Lung Manifestation: A Retrospective Analysis 2026 ·ACR Open Rheumatology ·(unknown), (unknown), (unknown), Jan Dutz, (unknown), (unknown)	0
3	Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management—A Canadian Perspective 2025 ·Journal of Cutaneous Medicine and Surgery ·Fiona Lovegrove, Maxwell Sauder, Asfandyar Mufti, Jennifer Beecker, Jan Dutz, Mark G. Kirchhof, (unknown), (unknown), Perla Lansang	0
4	Tofacitinib therapy in refractory inflammatory myositis: a retrospective cohort study of 41 patients 2023 ·Lara D. Veeken ·(unknown), Julia Tan, (unknown), Jan Dutz, Kam Shojania, (unknown), (unknown), J. Antonio Aviña‐Zubieta, Kun Huang	13
5	Systematic literature review and network meta-analysis of therapies for psoriatic arthritis on patient-reported outcomes 2023 ·BMJ Open ·Peter Nash, Jan Dutz, (unknown), Barkha P. Patel, (unknown), M. Shawi, (unknown), James Cheng‐Chung Wei	4
6	Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel 2023 ·Dermatology and Therapy ·Kim Papp, Barbara Melosky, Sandeep Sehdev, Sébastien J. Hotte, Jennifer Beecker, Mark G. Kirchhof, Irina Turchin, Jan Dutz, Melinda Gooderham, Robert Gniadecki, Chih-ho Hong, Jo Lambert, Charles Lynde, Vimal H. Prajapati, Ronald Vender	10
7	A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes 2021 ·PubMed ·Ashish Marwaha, (unknown), Anne M. Pesenacker, Laura Cook, (unknown), S. Alice Long, Jennie H. M. Yang, Kirsten A. Ward‐Hartstonge, (unknown), Clara Domingo‐Vila, (unknown), Kristina M. Harris, Timothy Tree, Megan K. Levings, Thomas G. Elliott, Rusung Tan, Jan Dutz	16
8	Infection risk of dermatologic therapeutics during the COVID‐19 pandemic: an evidence‐based recalibration 2020 ·International Journal of Dermatology ·Feras M. Ghazawi, (unknown), Jan Dutz, Mark G. Kirchhof	14
9	Correction: Transcriptome Analysis Reveals Markers of Aberrantly Activated Innate Immunity in Vitiligo Lesional and Non-Lesional Skin 2013 ·PLoS ONE ·Richard Yu, Raewyn Broady, Yuanshen Huang, Yang Wang, Jie Yu, Min Gao, Megan K. Levings, (unknown), Shengquan Zhang, Aie Xu, Mingwan Su, Jan Dutz, Xuejun Zhang, Youwen Zhou	4
10	Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach 2013 ·Journal of the American Academy of Dermatology ·Afsáneh Alavi, Jürg Hafner, Jan Dutz, Dieter Mayer, R. Gary Sibbald, Paulo Ricardo Criado, Patricia Senet, (unknown), Tania J. Phillips, Marco Romanelli, Robert S. Kirsner	76
11	Reversible retiform purpura: a sign of cocaine use 2011 ·Canadian Medical Association Journal ·Christina S. Han, Gayatri Sreenivasan, Jan Dutz	14
12	TLR9 Blockade Inhibits Activation of Diabetogenic CD8+ T Cells and Delays Autoimmune Diabetes 2010 ·The Journal of Immunology ·Yiqun Zhang, Andrew S. Lee, Afshin Shameli, Xuan Geng, Diane T. Finegood, Pere Santamaría, Jan Dutz	68
13	Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol 2009 ·The Journal of Immunology ·Mehran Ghoreishi, Paxton Bach, (unknown), (unknown), James C. Fleet, Jan Dutz	124
14	Tolerance Induction by Transcutaneous Immunization through Ultraviolet-Irradiated Skin Is Transferable through CD4+CD25+ T Regulatory Cells and Is Dependent on Host-Derived IL-10 2006 ·The Journal of Immunology ·Mehran Ghoreishi, Jan Dutz	68
15	Decidual NK Cells Alter In Vitro First Trimester Extravillous Cytotrophoblast Migration: A Role for IFN-γ 2006 ·The Journal of Immunology ·Yuxiang Hu, Jan Dutz, Colin D. MacCalman, Paul J. Yong, Rusung Tan, Peter von Dadelszen	111
16	Cutting Edge: Signaling Lymphocytic Activation Molecule-Associated Protein Controls NKT Cell Functions 2005 ·The Journal of Immunology ·Brian K. Chung, (unknown), Jan Dutz, Cox Terhorst, Rusung Tan	143
17	Regulation of Autoimmune Diabetes by Complete Freund’s Adjuvant Is Mediated by NK Cells 2004 ·The Journal of Immunology ·I‐Fang Lee, Huilian Qin, Jacqueline D. Trudeau, Jan Dutz, Rusung Tan	84
18	In Situ β Cell Death Promotes Priming of Diabetogenic CD8 T Lymphocytes 2002 ·The Journal of Immunology ·Yiqun Zhang, Bronwyn A. O’Brien, Jacqueline D. Trudeau, Rusung Tan, Pere Santamaría, Jan Dutz	89
19	Necrotizing Cutaneous Cryoglobulinemic Vasculopathy 2001 ·Plastic & Reconstructive Surgery ·Raman C. Mahabir, (unknown), W. Barrett Benny, Jan Dutz, C. F. T. Snelling	7
20	Perspectives in Diabetes. Neonatal beta-Cell Apoptosis. A Trigger for Autoimmune Diabetes? 2000 ·Clinical Diabetology ·Jacqueline D. Trudeau, Jan Dutz, Edith Arany, David J. Hill, (unknown), Diane T. Finegood	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact